Cathepsin K-Mediated Phenotypic Switching of Pulmonary Artery Smooth Muscle Contributed to the Development of Chronic Stress-related Pulmonary Hypertension in Mice
Abstract Aims Exposure to chronic psychological stress is a risk factor for metabolic pulmonary artery hypertension (PAH). Given the critical role of lysosomal cathepsin K (CTSK) in human pathobiology, we examined the role of CTSK in stress-related PAH, focusing on TGFβ/TGF-βR2-SMAD2/3 signaling-mediated switching of the phenotypical changes pf pulmonary artery smooth muscle cells (PASMCs). Methods and Results Eight-week-old male wild-type (CTSK +/+ ) and CTSK-knockout (CTSK −/− ) mice were subjected to hypoxia ± the tyrosine-kinase inhibitor SU-5416 with or without chronic restraint stress (CRS). Upon model establishment, the right-ventricular systolic pressure and vascular remodeling were quantified by echocardiography, micro-tip pressure sensor catheter, and biological and histomorphometry methods. Single-cell RNA sequencing (scRNA-seq) revealed elevated CTSK expression in PASMCs from idiopathic PAH patients. In mice, hypoxia ± SU-5416 induced CTSK expression and triggered PAH pathology that was markedly exacerbated by superimposed CRS. Genetic deletion of CTSK attenuated key features of PAH, including right-ventricular systolic pressure elevation and vascular remodeling, as well as a shift of PASMCs towards a synthetic phenotype characterized by increased expressions of extracellular-matrix genes (fibronectin, CTSK, and collagen I), a parallel induction of synthetic markers (TGF-β, VIM, and VCAN), and a decrease in contractile genes (SM22α, CNN1, and ATAC2). Mechanistically, CTSK formed a positive-feedback loop with TGF-β–SMAD2/3 signaling. In PASMCs, the silencing of CTSK abolished hypoxia- and stress-serum-induced cell proliferation and disrupted this loop, whereas CTSK overexpression amplified both. Conclusions These results identified CTSK as a critical contributor to PAH pathogenesis, particularly under chronic stress conditions. CTSK drives disease progression by enforcing a self-amplifying CTSK–TGF-β–SMAD2/3 circuit that switches PASMC phenotype change and proliferation.
Authors
- Shangzhi Shu (ORCID: https://orcid.org/0000-0001-7462-5124)
- Xueling Yue (ORCID: https://orcid.org/0000-0002-8589-5397)
- Meiping Zhang (ORCID: https://orcid.org/0009-0008-4517-7420)
- Xian Wu Cheng (ORCID: https://orcid.org/0000-0002-9758-0632)
- Jinshun Piao (ORCID: https://orcid.org/0009-0000-2234-4371)
- Songzhen Zhao (ORCID: https://orcid.org/0009-0007-7378-8619)
- Miao Li (ORCID: https://orcid.org/0000-0002-4360-1960)
- Chaoqun Huang
- Meiling Piao
- Chunzi Jin
- Mantong Zhao
- Ran Chen
Institutions
- First Hospital of Jilin University (CN)
- Yanbian University Hospital (CN)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-17
- DOI
- https://doi.org/10.21203/rs.3.rs-11565789/v1
- Primary Topic
- Pulmonary Hypertension Research and Treatments
- Type
- preprint
Funders
- National Natural Science Foundation of China
- People's Government of Jilin Province